DelveInsight’s Perennial Allergic Rhinitis Market Insights report includes a comprehensive understanding of current treatment practices, emerging perennial allergic rhinitis drugs, market share of ...

Volatile organic compounds in exhaled breath may help distinguish patients with allergic rhinitis from patients with ...

Please provide your email address to receive an email when new articles are posted on . Safety and efficacy data from a recent study demonstrated superiority of non-aqueous beclomethasone dipropionate ...

Results from short-term studies of patients with seasonal allergies generally have shown that nasal steroids relieve symptoms more effectively than do antihistamines. But what about long-term outcomes ...

QNASL Approved for Seasonal and Perennial Allergic Rhinitis Teva announced that the FDA has approved QNASL (beclomethasone dipropionate) Nasal Aerosol, a non-aqueous, "dry" nasal aerosol ...

SEATTLE — GSP301, a nasal spray containing a fixed-dose combination of olopatadine hydrochloride/mometasone furoate, is a safe and effective treatment for reducing ...

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol ...

Fluticasone furoate 27.5 µg/spray; alcohol-free. Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. The exact mechanism by which this ...

Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...

There is a link between alcohol consumption and increased risk of perennial allergic rhinitis, according to a recent Danish study of 5,870 young adult women. The study, published in the July issue of ...

Considering taking supplements to treat Perennial rhinitis? Below is a list of common natural remedies used to treat or reduce the symptoms of Perennial rhinitis. Follow the links to read common uses, ...

(MENAFN- GlobeNewsWire - Nasdaq) The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies ...